Is the tumour microenvironment a critical prognostic factor in early-stage colorectal cancer?

por Nyamundanda, G, Fontana, E, Sadanandam, A
Publicado en Ann Oncol (2019)

Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study

por Borelli, B., Fontana, E., Giordano, M., Antoniotti, C., Lonardi, S., Bergamo, F., Pietrantonio, F., Morano, F., Tamburini, E., Boccaccino, A., Santini, D., Zucchelli, G., Pella, N., Maiello, E., Passardi, A., Zaniboni, A., Ugolini, C., Fontanini, G., Falcone, A., Nyamundanda, G., Sadanandam, A., Cremolini, C.
Publicado en ESMO Open (2021)

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial

por Smyth, E C, Nyamundanda, G, Cunningham, D, Fontana, E, Ragulan, C, Tan, I B, Lin, S J, Wotherspoon, A, Nankivell, M, Fassan, M, Lampis, A, Hahne, J C, Davies, A R, Lagergren, J, Gossage, J A, Maisey, N, Green, M, Zylstra, J L, Allum, W H, Langley, R E, Tan, P, Valeri, N, Sadanandam, A
Publicado en Ann Oncol (2018)